<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="25/04/2006" creator="Noriko Katsu" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=7609053"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>7609053</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">The <term sem="DNA_domain_or_region" id="T1" lex="peri-kappa_B_site">peri-kappa B site</term> mediates <term sem="Other" id="T2" lex="human_immunodeficiency_virus_type_2_enhancer_activation"><term sem="DNA_domain_or_region" id="T3" lex="human_immunodeficiency_virus_type_2_enhancer"><term sem="Virus" id="T4" lex="human_immunodeficiency_virus_type_2">human immunodeficiency virus type 2</term> enhancer</term> activation</term> in <term sem="Cell_natural" id="T5" lex="monocyte">monocytes</term> but not in <term sem="Cell_natural" id="T6" lex="T_cell">T cells</term>.</sentence>
<event id="E1">
<type class="Positive_regulation" />
<theme idref="E29" />
<cause idref="T1" />
<clue>The peri-kappa B site <clueType>mediates</clueType> human immunodeficiency virus type 2 enhancer activation <clueLoc>in monocytes</clueLoc> but not in T cells.</clue>
</event>
<event assertion="non-exist" id="E2">
<type class="Positive_regulation" />
<theme idref="E29" />
<cause idref="T1" />
<clue>The peri-kappa B site <clueType>mediates</clueType> human immunodeficiency virus type 2 enhancer activation in monocytes but not <clueLoc>in T cells</clueLoc>.</clue>
</event>
<event id="E29">
<type class="Positive_regulation" />
<theme idref="T3" />
<clue>The peri-kappa B site mediates human immunodeficiency virus type 2 enhancer <clueType>activation</clueType> in monocytes but not in T cells.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term sem="Virus" id="T7" lex="human_immunodeficiency_virus_type_2">Human immunodeficiency virus type 2</term> (<term sem="Virus" id="T8" lex="HIV-2">HIV-2</term>), like <term sem="Virus" id="T9" lex="HIV-1">HIV-1</term>, causes <term sem="Other" id="T10" lex="AIDS">AIDS</term> and is associated with <term sem="Other" id="T11" lex="AIDS">AIDS</term> cases primarily in West Africa.</sentence>
<event id="E3">
<type class="Biological_process" />
<theme idref="T10" />
<cause idref="T8" />
<clue>Human immunodeficiency virus type 2 (HIV-2), like HIV-1, <clueType>causes</clueType> AIDS and is associated with AIDS cases primarily in West Africa.</clue>
</event>
<event id="E4">
<type class="Biological_process" />
<theme idref="T10" />
<cause idref="T9" />
<clue>Human immunodeficiency virus type 2 (HIV-2), like HIV-1, <clueType>causes</clueType> AIDS and is associated with AIDS cases primarily in West Africa.</clue>
<comment>CAUTION: SEE</comment></event>
<sentence id="S3"><term sem="Virus" id="T12" lex="HIV-1">HIV-1</term> and <term sem="Virus" id="T13" lex="HIV-2">HIV-2</term> display significant differences in <term sem="Other" id="T14" lex="nucleic_acid_sequence">nucleic acid sequence</term> and in the natural history of clinical disease.</sentence>
<sentence id="S4">Consistent with these differences, we have previously demonstrated that the <term sem="DNA_domain_or_region" id="T15" lex="enhancer/promoter_region">enhancer/promoter region</term> of <term sem="Virus" id="T16" lex="HIV-2">HIV-2</term> functions quite differently from that of <term sem="Virus" id="T17" lex="HIV-1">HIV-1</term>.</sentence>
<sentence id="S5">Whereas activation of the <term sem="DNA_domain_or_region" id="T18" lex="HIV-1_enhancer"><term sem="Virus" id="T19" lex="HIV-1">HIV-1</term> enhancer</term> following <term sem="Other" id="T20" lex="T-cell_stimulation"><term sem="Cell_natural" id="A1">T-cell</term> stimulation</term> is mediated largely through binding of the <term sem="Protein_family_or_group" id="T21" lex="transcription_factor">transcription factor</term> <term sem="Protein_molecule" id="T22" lex="NF-kappa_B">NF-kappa B</term> to two adjacent <term sem="DNA_domain_or_region" id="A3"><term sem="DNA_domain_or_region" id="T23" lex="kappa_B_site">kappa B sites</term> in the <term sem="DNA_domain_or_region" id="T24" lex="HIV-1_long_terminal_repeat"><term sem="Virus" id="T25" lex="HIV-1">HIV-1</term> long terminal repeat</term></term>, activation of the <term sem="DNA_domain_or_region" id="T26" lex="HIV-2_enhancer"><term sem="Virus" id="T27" lex="HIV-2">HIV-2</term> enhancer</term> in <term sem="Cell_natural" id="T28" lex="monocyte">monocytes</term> and <term sem="Cell_natural" id="T29" lex="T_cell">T cells</term> is dependent on four <term sem="DNA_domain_or_region" id="T30" lex="cis-acting_element">cis-acting elements</term>: a single <term sem="DNA_domain_or_region" id="T31" lex="kappa_B_site">kappa B site</term>, two <term sem="DNA_domain_or_region" id="T32" lex="purine-rich_binding_site">purine-rich binding sites</term>, <term sem="DNA_domain_or_region" id="T33" lex="PuB1">PuB1</term> and <term sem="DNA_domain_or_region" id="T34" lex="PuB2">PuB2</term>, and a <term sem="DNA_domain_or_region" id="T35" lex="pets_site">pets site</term>.</sentence>
<event id="E5">
<type class="Physiological_process" />
<theme idref="A1" />
<clue>Whereas activation of the HIV-1 enhancer following T-cell <clueType>stimulation</clueType> is mediated largely through binding of the transcription factor NF-kappa B to two adjacent kappa B sites in the HIV-1 long terminal repeat, activation of the HIV-2 enhancer in monocytes and T cells is dependent on four cis-acting elements: a single kappa B site, two purine-rich binding sites, PuB1 and PuB2, and a pets site.</clue>
</event>
<event id="E6">
<type class="Positive_regulation" />
<theme idref="T18" />
<cause idref="E5" />
<clue>Whereas <clueType>activation</clueType> <linkTheme>of</linkTheme> the HIV-1 enhancer <linkCause>following</linkCause> T-cell stimulation is mediated largely through binding of the transcription factor NF-kappa B to two adjacent kappa B sites in the HIV-1 long terminal repeat, activation of the HIV-2 enhancer in monocytes and T cells is dependent on four cis-acting elements: a single kappa B site, two purine-rich binding sites, PuB1 and PuB2, and a pets site.</clue>
</event>
<event id="E30">
<type class="Positive_regulation" />
<theme idref="T18" />
<cause idref="E7" />
<clue>Whereas activation of the HIV-1 enhancer following T-cell stimulation is <clueType>mediated</clueType> largely <linkCause>through</linkCause> binding of the transcription factor NF-kappa B to two adjacent kappa B sites in the HIV-1 long terminal repeat, activation of the HIV-2 enhancer in monocytes and T cells is dependent on four cis-acting elements: a single kappa B site, two purine-rich binding sites, PuB1 and PuB2, and a pets site.</clue>
</event>
<event id="E7">
<type class="Binding" />
<theme idref="T22" />
<theme idref="A3" />
<clue>Whereas activation of the HIV-1 enhancer following T-cell stimulation is mediated largely through <clueType>binding</clueType> <linkTheme>of</linkTheme> the transcription factor NF-kappa B <linkTheme>to</linkTheme> two adjacent kappa B sites in the HIV-1 long terminal repeat, activation of the HIV-2 enhancer in monocytes and T cells is dependent on four cis-acting elements: a single kappa B site, two purine-rich binding sites, PuB1 and PuB2, and a pets site.</clue>
<comment>TPS: A3</comment></event>
<event id="E8">
<type class="Positive_regulation" />
<theme idref="T26" />
<clue>Whereas activation of the HIV-1 enhancer following T-cell stimulation is mediated largely through binding of the transcription factor NF-kappa B to two adjacent kappa B sites in the HIV-1 long terminal repeat, <clueType>activation</clueType> <linkTheme>of</linkTheme> the HIV-2 enhancer <clueLoc>in monocytes and T cells</clueLoc> is dependent on four cis-acting elements: a single kappa B site, two purine-rich binding sites, PuB1 and PuB2, and a pets site.</clue>
</event>
<event id="E9">
<type class="Regulation" />
<theme idref="E8" />
<cause idref="T31" />
<clue>Whereas activation of the HIV-1 enhancer following T-cell stimulation is mediated largely through binding of the transcription factor NF-kappa B to two adjacent kappa B sites in the HIV-1 long terminal repeat, activation of the HIV-2 enhancer in monocytes and T cells is <clueType>dependent</clueType> <linkCause>on</linkCause> four <corefCause>cis-acting elements</corefCause>: a single kappa B site, two purine-rich binding sites, PuB1 and PuB2, and a pets site.</clue>
</event>
<event id="E10">
<type class="Regulation" />
<theme idref="E8" />
<cause idref="T33" />
<clue>Whereas activation of the HIV-1 enhancer following T-cell stimulation is mediated largely through binding of the transcription factor NF-kappa B to two adjacent kappa B sites in the HIV-1 long terminal repeat, activation of the HIV-2 enhancer in monocytes and T cells is <clueType>dependent</clueType> <linkCause>on</linkCause> four <corefCause idref1="T32">cis-acting elements</corefCause>: a single kappa B site, two <corefCause idref1="T33">purine-rich binding sites</corefCause>, PuB1 and PuB2, and a pets site.</clue>
<comment>corefCause=multilayer</comment></event>
<event id="E11">
<type class="Regulation" />
<theme idref="E8" />
<cause idref="T34" />
<clue>Whereas activation of the HIV-1 enhancer following T-cell stimulation is mediated largely through binding of the transcription factor NF-kappa B to two adjacent kappa B sites in the HIV-1 long terminal repeat, activation of the HIV-2 enhancer in monocytes and T cells is <clueType>dependent</clueType> <linkCause>on</linkCause> four <corefCause idref1="T32">cis-acting elements</corefCause>: a single kappa B site, two <corefCause idref1="T34">purine-rich binding sites</corefCause>, PuB1 and PuB2, and a pets site.</clue>
<comment>corefCause=multilayer</comment></event>
<event id="E12">
<type class="Regulation" />
<theme idref="E8" />
<cause idref="T35" />
<clue>Whereas activation of the HIV-1 enhancer following T-cell stimulation is mediated largely through binding of the transcription factor NF-kappa B to two adjacent kappa B sites in the HIV-1 long terminal repeat, activation of the HIV-2 enhancer in monocytes and T cells is <clueType>dependent</clueType> <linkCause>on</linkCause> four <corefCause>cis-acting elements</corefCause>: a single kappa B site, two purine-rich binding sites, PuB1 and PuB2, and a pets site.</clue>
</event>
<sentence id="S6">We have now identified a novel <term sem="DNA_family_or_group" id="T36" lex="cis-acting_element">cis-acting element</term> within the <term sem="DNA_domain_or_region" id="T37" lex="HIV-2_enhancer"><term sem="Virus" id="T38" lex="HIV-2">HIV-2</term> enhancer</term>, immediately upstream of the <term sem="DNA_domain_or_region" id="T39" lex="kappa_B_site">kappa B site</term>, designated <term sem="DNA_domain_or_region" id="T40" lex="peri-kappa_B">peri-kappa B</term>.</sentence>
<sentence id="S7">This site is conserved among isolates of <term sem="Virus" id="T41" lex="HIV-2">HIV-2</term> and the closely related <term sem="Virus" id="T42" lex="simian_immunodeficiency_virus">simian immunodeficiency virus</term>, and <term sem="Other" id="T43" lex="transfection_assay">transfection assays</term> show this site to mediate <term sem="Other" id="T44" lex="HIV-2_enhancer_activation"><term sem="DNA_domain_or_region" id="T45" lex="HIV-2_enhancer"><term sem="Virus" id="T46" lex="HIV-2">HIV-2</term> enhancer</term> activation</term> following stimulation of <term sem="Cell_cultured" id="T47" lex="monocytic_cell_line">monocytic</term> but not <term sem="Cell_cultured" id="T48" lex="T-cell_line">T-cell lines</term>.</sentence>
<event id="E13">
<type class="Positive_regulation" />
<theme idref="E17" />
<cause idref="T40" />
<clue>This site is conserved among isolates of HIV-2 and the closely related simian immunodeficiency virus, and <clueExperiment>transfection assays</clueExperiment> show <corefCause>this site</corefCause> to <clueType>mediate</clueType> HIV-2 enhancer activation following stimulation of monocytic but not T-cell lines.</clue>
</event>
<event assertion="non-exist" id="E14">
<type class="Positive_regulation" />
<theme idref="E18" />
<cause idref="T40" />
<clue>This site is conserved among isolates of HIV-2 and the closely related simian immunodeficiency virus, and <clueExperiment>transfection assays</clueExperiment> show <corefCause>this site</corefCause> to <clueType>mediate</clueType> HIV-2 enhancer activation following stimulation of monocytic but not T-cell lines.</clue>
</event>
<event id="E15">
<type class="Physiological_process" />
<theme idref="T47" />
<clue>This site is conserved among isolates of HIV-2 and the closely related simian immunodeficiency virus, and transfection assays show this site to mediate HIV-2 enhancer activation following <clueType>stimulation</clueType> <linkTheme>of</linkTheme> monocytic but not T-cell lines.</clue>
</event>
<event id="E16">
<type class="Physiological_process" />
<theme idref="T48" />
<clue>This site is conserved among isolates of HIV-2 and the closely related simian immunodeficiency virus, and transfection assays show this site to mediate HIV-2 enhancer activation following <clueType>stimulation</clueType> <linkTheme>of</linkTheme> monocytic but not T-cell lines.</clue>
</event>
<event id="E17">
<type class="Positive_regulation" />
<theme idref="T45" />
<cause idref="E15" />
<clue>This site is conserved among isolates of HIV-2 and the closely related simian immunodeficiency virus, and transfection assays show this site to mediate HIV-2 enhancer <clueType>activation</clueType> <linkCause>following</linkCause> stimulation of monocytic but not T-cell lines.</clue>
</event>
<event id="E18">
<type class="Positive_regulation" />
<theme idref="T45" />
<cause idref="E16" />
<clue>This site is conserved among isolates of HIV-2 and the closely related simian immunodeficiency virus, and transfection assays show this site to mediate HIV-2 enhancer <clueType>activation</clueType> <linkCause>following</linkCause> stimulation of monocytic but not T-cell lines.</clue>
</event>
<sentence id="S8">This is the first description of an <term sem="DNA_domain_or_region" id="T49" lex="HIV-2_enhancer_element"><term sem="Virus" id="T50" lex="HIV-2">HIV-2</term> enhancer element</term> which displays such monocyte specificity, and no comparable <term sem="DNA_domain_or_region" id="T51" lex="enhancer_element">enhancer element</term> has been clearly defined for <term sem="Virus" id="T52" lex="HIV-1">HIV-1</term>.</sentence>
<sentence id="S9">While a <term sem="Protein_family_or_group" id="T53" lex="nuclear_factor">nuclear factor</term>(s) from both <term sem="Cell_natural" id="T54" lex="peripheral_blood_monocyte">peripheral blood <term sem="Cell_natural" id="T55" lex="monocyte">monocytes</term></term> and <term sem="Cell_natural" id="T56" lex="T_cell">T cells</term> binds the <term sem="DNA_domain_or_region" id="T57" lex="peri-kappa_B_site">peri-kappa B site</term>, <term sem="Other" id="T58" lex="electrophoretic_mobility_shift_assay">electrophoretic mobility shift assays</term> suggest that either a different protein binds to this site in <term sem="Cell_natural" id="T59" lex="monocyte">monocytes</term> versus <term sem="Cell_natural" id="T60" lex="T_cell">T cells</term> or that the <term sem="Protein_family_or_group" id="A20">protein recognizing this <term sem="DNA_domain_or_region" id="T61" lex="enhancer_element">enhancer element</term></term> undergoes <term sem="Other" id="T62" lex="differential_modification">differential modification</term> in <term sem="Cell_natural" id="T63" lex="monocyte">monocytes</term> and <term sem="Cell_natural" id="T64" lex="T_cell">T cells</term>, thus supporting the transfection data.</sentence>
<event id="E19">
<type class="Binding" />
<theme idref="T53" />
<theme idref="T57" />
<clue>While a nuclear factor(s) <clueLoc>from both peripheral blood monocytes and T cells</clueLoc> <clueType>binds</clueType> the peri-kappa B site, electrophoretic mobility shift assays suggest that either a different protein binds to this site in monocytes versus T cells or that the protein recognizing this enhancer element undergoes differential modification in monocytes and T cells, thus supporting the transfection data.</clue>
</event>
<event uncertainty="probable" id="E21">
<type class="Binding" />
<theme idref="T53" />
<theme idref="T57" />
<clue>While a nuclear factor(s) from both peripheral blood monocytes and T cells binds the peri-kappa B site, <clueExperiment>electrophoretic mobility shift assays</clueExperiment> suggest that either a different <corefTheme idref1="T53">protein</corefTheme> <clueType>binds</clueType> <linkTheme>to</linkTheme> <corefTheme idref1="T57">this site</corefTheme> <clueLoc>in monocytes versus T cells</clueLoc> or that the protein recognizing this enhancer element undergoes differential modification in monocytes and T cells, thus supporting the transfection data.</clue>
</event>
<event id="E22">
<type class="Binding" />
<theme idref="T53" />
<theme idref="T57" />
<clue>While a nuclear factor(s) from both peripheral blood monocytes and T cells binds the peri-kappa B site, electrophoretic mobility shift assays suggest that either a different protein binds to this site in monocytes versus T cells or that <corefTheme idref1="T53">the protein</corefTheme> <clueType>recognizing</clueType> <corefTheme idref1="T57">this enhancer element</corefTheme> undergoes differential modification in monocytes and T cells, thus supporting the transfection data.</clue>
</event>
<event uncertainty="probable" id="E23">
<type class="Protein_modification" />
<theme idref="A20" />
<clue>While a nuclear factor(s) from both peripheral blood monocytes and T cells binds the peri-kappa B site, <clueExperiment>electrophoretic mobility shift assays</clueExperiment> suggest that either a different protein binds to this site in monocytes versus T cells or that the protein recognizing this enhancer element <linkTheme>undergoes</linkTheme> <clueType>differential modification</clueType> <clueLoc>in monocytes</clueLoc> and T cells, thus supporting the transfection data.</clue>
<comment>TPS: A20</comment></event>
<event id="E20">
<type class="Protein_modification" />
<theme idref="A20" />
<clue>While a nuclear factor(s) from both peripheral blood monocytes and T cells binds the peri-kappa B site, <clueExperiment>electrophoretic mobility shift assays</clueExperiment> suggest that either a different protein binds to this site in monocytes versus T cells or that the protein recognizing this enhancer element <linkTheme>undergoes</linkTheme> <clueType>differential modification</clueType> <clueLoc>in</clueLoc> monocytes and <clueLoc>T cells</clueLoc>, thus supporting the transfection data.</clue>
<comment>TPS: A20</comment></event>
<sentence id="S10">Further, while specific constitutive binding to the <term sem="DNA_domain_or_region" id="T65" lex="peri-kappa_B_site">peri-kappa B site</term> is seen in <term sem="Cell_natural" id="T66" lex="monocyte">monocytes</term>, stimulation with <term sem="Organic_compound_other" id="T67" lex="phorbol_ester">phorbol esters</term> induces additional, specific <term sem="Other" id="A2">binding</term>.</sentence>
<event id="E24">
<type class="Binding" />
<theme idref="T65" />
<theme idref="T53" />
<clue>Further, while specific constitutive <clueType>binding</clueType> <linkTheme>to</linkTheme> the peri-kappa B site is seen <clueLoc>in monocytes</clueLoc>, stimulation with phorbol esters induces additional, specific binding.</clue>
<comment>NO COREFTHEME for T53</comment></event>
<event id="E25">
<type class="Positive_regulation" />
<theme idref="A2" />
<cause idref="E26" />
<clue>Further, while specific constitutive binding to the peri-kappa B site is seen in monocytes, stimulation with phorbol esters <clueType>induces</clueType> additional, specific binding.</clue>
</event>
<event id="E26">
<type class="Physiological_process" />
<theme idref="T66" />
<cause idref="T67" />
<clue>Further, while specific constitutive binding to the peri-kappa B site is seen in monocytes, <clueType>stimulation</clueType> <linkCause>with</linkCause> phorbol esters induces additional, specific binding.</clue>
</event>
<sentence id="S11">Understanding the <term sem="Other" id="T68" lex="monocyte-specific_function">monocyte-specific function</term> of the <term sem="Protein_molecule" id="T69" lex="peri-kappa_B_factor">peri-kappa B factor</term> may ultimately provide insight into the different role <term sem="Cell_natural" id="T70" lex="monocyte">monocytes</term> and <term sem="Cell_natural" id="T71" lex="T_cell">T cells</term> play in <term sem="Other" id="T72" lex="HIV_pathogenesis">HIV pathogenesis</term>.</sentence>
<event uncertainty="probable" id="E27">
<type class="Regulation" />
<theme idref="T72" />
<cause idref="T70" />
<clue>Understanding the monocyte-specific function of the peri-kappa B factor may ultimately provide insight into the different <clueType>role</clueType> monocytes and T cells <clueType>play</clueType> <linkTheme>in</linkTheme> HIV pathogenesis.</clue>
</event>
<event uncertainty="probable" id="E28">
<type class="Regulation" />
<theme idref="T72" />
<cause idref="T71" />
<clue>Understanding the monocyte-specific function of the peri-kappa B factor may ultimately provide insight into the different <clueType>role</clueType> monocytes and T cells <clueType>play</clueType> <linkTheme>in</linkTheme> HIV pathogenesis.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
